Your browser doesn't support javascript.
loading
[Pharmacology of nicotine]. / Pharmacologie de la nicotine.
Bourlaud, I; Underner, M; Perault, M C; Patte, F.
Afiliação
  • Bourlaud I; Service de Pneumologie, CHU, Poitiers.
Rev Mal Respir ; 9(4): 367-74, 1992.
Article em Fr | MEDLINE | ID: mdl-1509183
Nicotine has a small molecular weight and is absorbed via the mucosa (Guccal or nasal), the pulmonary alveoli and the skin. The phenomenon of autotitration explains how a dependent smoker can unconsciously change his method of smoking to maintain a steady nicotine level. Nicotine leads to a liberation of catecholamines by acting on the nervous system through the intermediary of nicotine receptors. There is increased vigilance and powers of intellectual concentration, an awakening reaction and some anxiolytic and euphoriant effects. From the cardiac stand point there is an increased heart rate and blood pressure, as a result of the sympathomimetic effects. Elimination is via the kidneys as unchanged nicotine, cotinine and 1'-N-oxide of nicotine. Nicotine has an addictive action and is capable of inducing pharmacological dependency, tolerance and withdrawal syndrome in cases of abrupt cessation. A knowledge of the pharmacology of nicotine is important in the process of stopping smoking.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Prevenção do Hábito de Fumar / Nicotina Limite: Humans Idioma: Fr Ano de publicação: 1992 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Prevenção do Hábito de Fumar / Nicotina Limite: Humans Idioma: Fr Ano de publicação: 1992 Tipo de documento: Article